Pedrinelli R, Tarazi R C
Circulation. 1984 Jun;69(6):1171-6. doi: 10.1161/01.cir.69.6.1171.
To the extent that calcium availability is the final common mediator of vasoconstrictor responses, calcium entry blockade might interfere with physiologic responses to adrenergic stimulation. To test this hypothesis, we studied the effects of calcium entry blockade on pressor responses to norepinephrine in pithed, normal Sprague-Dawley rats in two different ways: (1) by evaluating the effects on pressor responsiveness to exogenous norepinephrine during differential blockade of alpha 1-(prazosin, 0.3 mg/kg) and of alpha 2-receptors (yohimbine, 0.3 mg/kg) and (2) by comparing the effects of calcium entry blockade with those of prazosin and those of rauwolscine (a specific alpha 2-antagonist) on pressor responses to infusions of both endogenously released norepinephrine (electrical stimulation of the pithing rod) and exogenous norepinephrine. In the presence of alpha 1-blockade, both nitrendipine (0.01 mg/kg) and verapamil (0.6 mg/kg) shifted the norepinephrine pressor dose-response curve to the right but were ineffective in alpha 2-blocked animals. Furthermore, nitrendipine (range 0.01 to 0.3 mg/kg) proved to be more effective (p less than .001) against exogenous norepinephrine than against electrical stimulation of the spinal cord, a behavior opposite that of selective alpha 1-blockade (prazosin) and directionally comparable to that of selective alpha 2-antagonism (rauwolscine). These data indicate that calcium entry blockade in vivo preferentially antagonizes the alpha 2-pressor component of exogenous norepinephrine. In addition, both calcium entry blockers were consistently more active (p less than .01) than rauwolscine (0.01 to 1 mg/kg) in antagonizing the pressor response to neural stimulation, suggesting that mechanisms different from "classical" alpha 2-antagonism may also contribute to the overall effect of calcium entry blockade on the adrenergic control of peripheral vascular tone.
鉴于钙的可利用性是血管收缩反应的最终共同介质,钙内流阻断可能会干扰对肾上腺素能刺激的生理反应。为了验证这一假设,我们以两种不同方式研究了钙内流阻断对脊髓横断的正常Sprague-Dawley大鼠去甲肾上腺素升压反应的影响:(1)通过评估在分别阻断α1-受体(哌唑嗪,0.3mg/kg)和α2-受体(育亨宾,0.3mg/kg)期间对外源性去甲肾上腺素升压反应性的影响;(2)通过比较钙内流阻断剂与哌唑嗪和萝芙木碱(一种特异性α2-拮抗剂)对输注内源性释放的去甲肾上腺素(脊髓横断棒的电刺激)和外源性去甲肾上腺素的升压反应的影响。在存在α1-阻断的情况下,尼群地平(0.01mg/kg)和维拉帕米(0.6mg/kg)均使去甲肾上腺素升压剂量-反应曲线右移,但在α2-阻断的动物中无效。此外,尼群地平(0.01至0.3mg/kg范围)对外源性去甲肾上腺素的作用比脊髓电刺激更有效(p<0.001),这种行为与选择性α1-阻断(哌唑嗪)相反,且在方向上与选择性α2-拮抗(萝芙木碱)相当。这些数据表明,体内钙内流阻断优先拮抗外源性去甲肾上腺素的α2-升压成分。此外,两种钙内流阻断剂在拮抗对神经刺激的升压反应方面始终比萝芙木碱(0.01至1mg/kg)更有效(p<0.01),这表明不同于“经典”α2-拮抗的机制也可能有助于钙内流阻断对外周血管张力肾上腺素能控制的总体作用。